The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Is The Forecasted Market Value Of The Cardiac Marker Market Across 2026–2030?
The cardiac marker market size has experienced rapid expansion in recent years. This market is projected to expand from $12.38 billion in 2025 to $13.95 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 12.7%. Historically, this growth has been fueled by factors such as the rising incidence of cardiovascular diseases, the broadening of hospital laboratory infrastructure, an increased demand for emergency cardiac testing, a greater dependence on biomarker-based diagnosis, and advancements in assay sensitivity.
The cardiac marker market is projected for significant expansion in the coming years. By 2030, this market is anticipated to reach $22.7 billion, demonstrating a compound annual growth rate (CAGR) of 12.9%. This growth during the forecast period is propelled by factors such as a greater need for quicker diagnostic test results, enhanced integration of cardiac diagnostics with digital systems, the proliferation of point-of-care testing sites, wider acceptance of sophisticated biomarker panels, and an increased emphasis on precision cardiology. Key trends anticipated during the same period encompass the heightened utilization of high-specificity cardiac marker panels, increased deployment of automated immunoassay systems, a growing desire for swift cardiac diagnosis, the broadening of multiparametric testing methodologies, and a stronger focus on clinical decision support mechanisms.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10053&type=smp
What Primary Drivers Are Shaping The Development Of The Cardiac Marker Market?
The increasing occurrence of cardiac conditions is anticipated to drive expansion in the cardiac marker market moving ahead. These conditions encompass various ailments impacting the heart’s structure or function, leading to diverse health issues. Cardiac markers play a crucial role in the diagnosis and oversight of numerous heart-related ailments, such as heart attacks, angina, heart failure, and other cardiovascular problems. Consequently, there has been an uptick in the need for diagnostic tests utilizing cardiac markers. For instance, in January 2024, the American Heart Association, a US-based non-profit organization, reported that the age-adjusted death rate from cardiovascular disease increased to 233.3 per 100,000 in 2024, which was a 4.0% rise from 224.4 per 100,000 in 2023. This escalating incidence of cardiac diseases is therefore poised to further stimulate the growth of the cardiac marker market.
What Segmentation Levels Are Considered In The Cardiac Marker Market?
The cardiac marker market covered in this report is segmented –
1) By Biomarker: Troponin, Creatine Kinase-MB (CK-MB), B-type Natriuretic Peptide (BNP), Myoglobin, Other Biomarkers
2) By Product: Reagent, Instrument, Chemiluminescence, Immunofluorescence, Immunochromatography, ELISA
3) By Indication: Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome, Other Indications
4) By End User: Laboratory Testing Facilities, Hospital Labs, Reference Labs, Contract Testing Labs, Point-Of-Care Testing Facilities, Academic Institutions
Subsegments:
1) By Troponin: Troponin I, Troponin T, Troponin Diagnostic Kits
2) By Creatine Kinase-MB (CK-MB): CK-MB Test Kits, CK-MB Diagnostic Panels
3) By B-Type Natriuretic Peptide (BNP): BNP Test Kits, NT-ProBNP Test Kits, BNP Diagnostic Panels
4) By Myoglobin: Myoglobin Test Kits, Myoglobin Diagnostic Panels
5) By Other Biomarkers: Ischemia Modified Albumin (IMA), Heart Fatty Acid Binding Protein (HFABP), C-Reactive Protein (CRP)
What Trends Are Projected To Affect The Cardiac Marker Market?
Leading companies within the cardiac marker market are concentrating on the development of innovative products, such as high-sensitivity troponin I (hs-cTnI) and NT-proBNP cardiac biomarkers, to enhance their market revenues. High-sensitivity troponin I (hs-cTnI) and NT-proBNP are crucial cardiac biomarkers employed in the diagnosis, classification, and treatment of conditions. Illustratively, in October 2023, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., a China-based company known for medical equipment and solutions, unveiled its troponin I (hs-cTnI) and NT-proBNP cardiac biomarkers. The hs-cTn assay has exceeded the minimal requirements for hs-cTn in terms of its sensitivity, accuracy, and reliability for detecting myocardial damage. These new offerings are designed to facilitate improved treatment for cardiovascular illnesses by delivering reliable solutions that lead to better patient outcomes both within and beyond the scope of cardiovascular diseases.
Which Leading Firms Are Contributing To The Growth Of The Cardiac Marker Market?
Major companies operating in the cardiac marker market are Abbott Laboratories, F Hoffmann-La Roche AG, Siemens Healthineers AG, Danaher Corporation, Thermo Fisher Scientific Inc, bioMérieux SA, Bio-Rad Laboratories Inc, Beckman Coulter Inc, QuidelOrtho Corporation, Randox Laboratories Ltd, DiaSorin SpA, Tosoh Corporation, PerkinElmer Inc, Sysmex Corporation, Mindray Bio-Medical Electronics Co Ltd, Lepu Medical Technology Beijing Co Ltd, Trinity Biotech plc, Fujirebio Holdings Inc, Euroimmun AG, Abcam plc, Creative Diagnostics
Read the full cardiac marker market report here:
https://www.thebusinessresearchcompany.com/report/cardiac-marker-global-market-report
How Does The Cardiac Marker Market Perform Across Major Global Regions?
North America was the largest region in the cardiac marker market in 2025. The regions covered in the cardiac marker market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Cardiac Marker Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=10053&type=smp
Browse Through More Reports Similar to the Global Cardiac Marker Market 2026, By The Business Research Company
Arrhythmia Monitoring Devices Market Report 2026
https://www.thebusinessresearchcompany.com/report/arrhythmia-monitoring-devices-global-market-report
Cardiac Arrhythmia Monitoring Devices Market Report 2026
Wearable Heart Monitoring Devices Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model